Go Pro
LON:ABDX

Abingdon Health (ABDX) Share Price, News & Analysis

Abingdon Health logo
GBX 10.26 -0.49 (-4.54%)
As of 07:04 AM Eastern

About Abingdon Health Stock (LON:ABDX)

Advanced

Key Stats

Today's Range
10.26
11
50-Day Range
9.50
11.50
52-Week Range
5.50
13
Volume
61,729 shs
Average Volume
238,848 shs
Market Capitalization
£25.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests. The Company offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health aims to support the increase in need for rapid results across many industries and locations and produces lateral flow tests in areas such as infectious disease, clinical testing including companion diagnostics, animal health and environmental testing. Faster access to results allows for rapid decision making, targeted intervention and can support better outcomes. This ability has a significant role to play in improving life across the world. To support this aim Abingdon Health has also developed AppDx®, a customisable image capturing technology and algorithm that transforms a smartphone into a self-sufficient, standalone lateral-flow reader. Founded in 2008, Abingdon Health is headquartered in York, England.

Receive ABDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abingdon Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ABDX Stock News Headlines

Abingdon Healt. Regulatory News
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel
AIM Market Roundup: Abingdon Health, Autins, IQE
See More Headlines

ABDX Stock Analysis - Frequently Asked Questions

Abingdon Health's stock was trading at GBX 6.27 at the beginning of 2026. Since then, ABDX shares have increased by 70.3% and is now trading at GBX 10.68.

Abingdon Health Plc (LON:ABDX) released its earnings results on Tuesday, March, 17th. The company reported ($0.43) earnings per share (EPS) for the quarter. Abingdon Health had a negative trailing twelve-month return on equity of 55.91% and a negative net margin of 33.88%.

Shares of ABDX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Abingdon Health investors own include 4D pharma (DDDD), genedrive (GDR), Novacyt (NCYT), Rolls-Royce Holdings plc (RR.L), Tullow Oil (TLW), Active Energy Group (AEG) and B&M European Value Retail (BME).

Company Calendar

Last Earnings
3/17/2026
Today
9/16/2026

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Life Sciences Tools & Services
Sub-Industry
Life Sciences Tools & Services
Current Symbol
LON:ABDX
CIK
N/A
Fax
N/A
Employees
84
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.81)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£796.37 thousand
Net Margins
-33.88%
Pretax Margin
N/A
Return on Equity
-55.91%
Return on Assets
-17.93%

Debt

Debt-to-Equity Ratio
15.05
Current Ratio
1.91
Quick Ratio
1.96

Sales & Book Value

Annual Sales
£9.57 million
Price / Sales
2.77
Cash Flow
GBX 4.67 per share
Price / Cash Flow
2.25
Book Value
GBX 0.73 per share
Price / Book
14.43

Miscellaneous

Outstanding Shares
252,751,000
Free Float
N/A
Market Cap
£26.54 million
Optionable
Not Optionable
Beta
0.13
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (LON:ABDX) was last updated on 9/16/2026 by MarketBeat.com Staff.
From Our Partners